Comparative analysis evidenced the miR-181d expression in glioma tissues as inversely correlated with a favourable prognosis in these patients and that the favourable effect of miR-181d is, at least partially, related to its effect in downmodulating MGMT mRNA expression (100). The gene discussed is MGMT; the disease is central nervous system cancer.